GS
Graig Suvannavejh Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
35
Avg Return
Past Year
Past Year
30%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
73%
Neutral
27%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
---|---|---|---|---|---|---|---|---|
Outperform
Maintained
| $35 |
35%
upside
| 4 | -7% |
0
%
| 25 Sep ‘25 25 days ago |
|
|
Outperform
Maintained
| $44 |
44%
upside
| 1 | +23% |
0
%
| 12 Sep ‘25 1 month ago |
|
|
Neutral
Maintained
| $4 |
75%
upside
| 1 | – |
–
| 12 Sep ‘25 1 month ago |
|
|
Outperform
Maintained
| $165 |
2%
downside
| 4 | +25% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
Neutral
Maintained
| $22 |
19%
downside
| 5 | – |
–
| 4 Aug ‘25 2 months ago |
|
|
Outperform
Upgraded
| $3.50 |
6%
upside
| 1 | +88% |
0
%
| 28 Jul ‘25 2 months ago |
|
|
Outperform
Maintained
| $5 |
176%
upside
| 1 | +25% |
0
%
| 16 Jul ‘25 3 months ago |
|
|
Outperform
Maintained
| $12 |
169%
upside
| 1 | +73% |
0
%
| 26 Jun ‘25 3 months ago |
|
|
Neutral
Downgraded
| $0.5000 |
747%
upside
| 2 | -63% |
0
%
| 26 Jun ‘25 3 months ago |
|
|
Outperform
Maintained
| $10 |
78%
upside
| 1 | +209% |
0
%
| 18 Jun ‘25 4 months ago |
|
|
Outperform
Maintained
| $11 |
47%
upside
| 2 | +27% |
0
%
| 20 May ‘25 5 months ago |
|
|
Outperform
Maintained
| $26 |
116%
upside
| 1 | +110% |
0
%
| 16 May ‘25 5 months ago |
|
|
Outperform
Maintained
| $8 |
48%
downside
| 2 | +137% |
0
%
| 14 May ‘25 5 months ago |
|
|
Neutral
Maintained
| $33 |
3%
downside
| 2 | – |
–
| 7 Apr ‘25 6 months ago |
|
|
Outperform
Maintained
| $216 |
64%
upside
| 5 | +9.8% |
0
%
| 27 Mar ‘25 6 months ago |
|
|
Neutral
Downgraded
| $132 |
0%
upside
| 2 | +36% |
0
%
| 24 Feb ‘25 7 months ago |
|
|
Buy
Upgraded
| $7.60 |
347%
upside
| 1 | -44% |
0
%
| 18 Nov ‘24 11 months ago |
|